Recent progresses and perspectives in autoimmune bullous diseases - 06/04/20
Doi : 10.1016/j.jaci.2020.02.020
Christian D. Sadik, MD a, b, Enno Schmidt, MD a, b, c, Detlef Zillikens, MD a, b, ⁎ 
, Takashi Hashimoto, MD d, ⁎
, Takashi Hashimoto, MD d, ⁎ a Department of Dermatology, Allergy, and Venereology, University of Lübeck, Lübeck, Germany
b Center for Research on Inflammation of the Skin (CRIS), University of Lübeck, Lübeck, Germany
c Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany
d Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
∗Corresponding author: Takashi Hashimoto, MD, Department of Dermatology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno, Osaka 545-8585, Japan.Department of DermatologyOsaka City University Graduate School of Medicine1-4-3 AsahimachiAbenoOsaka545-8585Japan∗∗Detlef Zillikens, MD, Department of Dermatology, University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.Department of DermatologyUniversity of LübeckLübeck23538Germany
Key words : Autoimmune bullous disease, epidermal basement membrane zone, desmosome, pathomechanisms, pemphigoid diseases
El texto completo de este artículo está disponible en PDF.
Esquema
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 145 - N° 4
P. 1145-1147 - avril 2020 Regresar al número
Artículo precedente
- Current perspective of the etiopathogenesis of delayed-type, and T-cell–mediated drug-related skin diseases
- Marc Vocanson, Dean J. Naisbitt, Jean-François Nicolas
- AAAAI Foundation Faculty Development awardees: 2020
- Zuhair K. Ballas
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?